# Trikafta

NDC: 51167-331
Generic name: Elexacaftor, Tezacaftor, and Ivacaftor
Labeler / Manufacturer: Vertex Pharmaceuticals Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: —
Marketing started: 20191021

FDA application: NDA212273

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51167-331"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51167-331
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f354423a-85c2-41c3-a9db-0f3aee135d8d